Judith Ann Clements

Judith Ann Clements

UNVERIFIED PROFILE

Are you Judith Ann Clements?   Register this Author

Register author
Judith Ann Clements

Judith Ann Clements

Publications by authors named "Judith Ann Clements"

Are you Judith Ann Clements?   Register this Author

9Publications

167Reads

20Profile Views

Integration of Two In-depth Quantitative Proteomics Approaches Determines the Kallikrein-related Peptidase 7 (KLK7) Degradome in Ovarian Cancer Cell Secretome.

Mol Cell Proteomics 2019 05 31;18(5):818-836. Epub 2019 Jan 31.

From the ‡Queensland University of Technology (QUT), Institute of Health and Biomedical Innovation (IHBI) and School of Biomedical Sciences at the Translational Research Institute, 37 Kent Street, Woolloongabba, Queensland, 4102, Australia;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/mcp.RA118.001304DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6495248PMC
May 2019

Mass spectrometry based proteomics analyses in kallikrein-related peptidase research: implications for cancer research and therapy.

Expert Rev Proteomics 2017 12 17;14(12):1119-1130. Epub 2017 Oct 17.

b School of Biomedical Sciences , Institute of Health and Biomedical Innovation (IHBI), Queensland University of Technology (QUT), Translational Research Institute , Woolloongabba , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14789450.2017.1389637DOI Listing
December 2017

Mass spectrometry-based determination of Kallikrein-related peptidase 7 (KLK7) cleavage preferences and subsite dependency.

Sci Rep 2017 07 28;7(1):6789. Epub 2017 Jul 28.

Queensland University of Technology (QUT), Institute of Health and Biomedical Innovation (IHBI) and School of Biomedical Sciences at the Translational Research Institute, 37 Kent Street, Woolloongabba, Queensland, 4102, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-017-06680-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533777PMC
July 2017

Lycopene reduces ovarian tumor growth and intraperitoneal metastatic load.

Am J Cancer Res 2017 1;7(6):1322-1336. Epub 2017 Jun 1.

Queensland University of Technology (QUT)60 Musk Avenue, Kelvin Grove, QLD 4059, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489781PMC
June 2017

Lycopene's Effects on Cancer Cell Functions within Monolayer and Spheroid Cultures.

Nutr Cancer 2016 25;68(2):350-63. Epub 2016 Mar 25.

a Institute of Health and Biomedical Innovation, Queensland University of Technology , Brisbane , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/01635581.2016.1150498DOI Listing
December 2016

Engineered microenvironments provide new insights into ovarian and prostate cancer progression and drug responses.

Adv Drug Deliv Rev 2014 Dec 23;79-80:193-213. Epub 2014 Jun 23.

Cancer and Molecular Medicine Program, Institute of Health and Biomedical Innovation, Queensland University of Technology, 60 Musk Avenue, Kelvin Grove, 4059 Brisbane, Australia; Australian Prostate Cancer Research Centre - Queensland, Queensland University of Technology, Translational Research Institute, 37 Kent Street, Woolloongabba, 4102 Brisbane, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.addr.2014.06.001DOI Listing
December 2014

Proteomic and other analyses to determine the functional consequences of deregulated kallikrein-related peptidase (KLK) expression in prostate and ovarian cancer.

Proteomics Clin Appl 2014 Jun 11;8(5-6):403-15. Epub 2014 May 11.

Institute of Health and Biomedical Innovation, Translational Research Institute, Queensland University of Technology, Brisbane, Australia; Australian Prostate Cancer Research Centre - Queensland, Translational Research Institute, Queensland University of Technology, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/prca.201300098DOI Listing
June 2014